Pancreatic Cancer Research

ResearcherSHOWA Medical UniversityNo recent work listed

Yasutsuna Sasaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6712-7116; OpenAlex author ID A5103187201. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers

Papers 3

  1. Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction. Co-author DOI 10.1111/cas.12851↗
  2. Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX. Last author DOI 10.18632/oncotarget.12007↗
  3. Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer? Co-author DOI 10.1111/cas.12708↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wataru Ichikawa · 2 shared papers, 2015–2016 · strength 0.10
  2. Yutaro Kubota · 2 shared papers, 2015–2016 · strength 0.10
  3. Yukio Ando · 1 shared paper, 2016 · strength 0.06
  4. Masato Nagino · 1 shared paper, 2016 · strength 0.06
  5. Ken-Ichi Fujita · 1 shared paper, 2016 · strength 0.06
  6. Takashi Shibata · 1 shared paper, 2016 · strength 0.06
  7. Osamu Maeda · 1 shared paper, 2016 · strength 0.06
  8. Tomoki Ebata · 1 shared paper, 2016 · strength 0.06
  9. Yasuhiro Kaga · 1 shared paper, 2016 · strength 0.05
  10. Yu Sunakawa · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.